| ID | Name | CAS | Data |
MW (g/mol) |
| 52-797-0 |
1,5,7-Trimethyl-2-nitro-imidazo[4,5,d]pyrimidin-4,6-dione
|
|
2 | 239.19 |
| 52-801-4 |
5-Cholesten-3-.beta.,27-diol-17,22-dione, TMS
|
|
2 | 719.36 |
| 52-880-7 |
5«beta»-Androstan-7«alpha»,17«alpha»-dimethyl-3«alpha»,17«beta»-diol, TMS
|
|
2 | 464.87 |
| 52-884-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, methylboronate
|
|
2 | 250.10 |
| 52-917-6 |
L-Serine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107715-93-5 |
2 | 447.88 |
| 53-065-1 |
Silane, diphenylpentyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 461.39 |
| 53-082-2 |
(E)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 1
|
|
2 | 507.57 |
| 53-090-3 |
3«alpha»,5«beta»,7«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 53-122-7 |
Benzaldehyde, 2-hydroxy, 3-nitro-5-tert.-octyl, oxime, TMS
|
|
2 | 382.60 |
| 53-127-2 |
2-Deoxy-D-ribose, tris(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 437.87 |
| 53-148-9 |
2H-Pyrido[3,2,b]-1,4-oxazin-3[4H]-one
|
|
2 | 150.14 |
| 53-163-2 |
4-ISOPROPYL-2,6,7-TRIOXA-1-PHOSPHABICYCLO[2.2.2]OCTANE 1-OXIDE
|
|
2 | 192.15 |
| 53-178-6 |
Naphtho[2,3-d]-1,2,3-triazin-4(3H)-one, 3-phenyl-
|
|
2 | 273.29 |
| 53-406-2 |
5«alpha»-Pregnan-3«beta»,20«beta»-diol, allyl-DMS
|
|
2 | 502.92 |
| 53-458-5 |
3«alpha»,5«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 651.20 |
| 53-489-1 |
Glycine, N-(2-methyl-1-oxo-2-propenyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55557-27-2 |
2 | 287.50 |
| 53-502-5 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTBDMS
|
|
2 | 532.99 |
| 53-635-8 |
(3R,4S)-3-Azido-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 370.56 |
| 53-644-8 |
2-Amino-3,5,7,8-tetrahydro-4,6-pteridinedione
|
1011-23-0 |
2 | 181.15 |
| 53-712-2 |
4-(tert-Butylamino)-6-ethyl-6-trimethylsilylamino-5H-1,3,5-triazin-2-one
|
|
2 | 283.45 |
| 53-737-5 |
5«beta»-Androst-1-ene-3«alpha»,17«alpha»-diol, per-TMS
|
|
2 | 434.80 |
| 53-771-7 |
N-tert-Butyl-N'-tert-butyldimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
2 | 311.50 |
| 53-789-8 |
Androst-1,4-dien-17«beta»-ol-3-one, TMS
|
|
2 | 430.77 |
| 53-895-0 |
Nickel complex of 2,2'-thiobis[4-(1,1,3,3-tetramethylbutyl)phenol]
|
|
2 | 501.39 |
| 53-903-0 |
4-Pregnen-20-«alpha»-ol-3,11-dione, MO-TMS
|
|
2 | 460.72 |
| 53-911-1 |
5-Methylaceto-5'-(3-buten-1-ynyl)-2,2'-bithienyl
|
|
2 | 288.39 |
| 53-929-2 |
5-«beta»-Pregnan-3-«alpha»-ol-11,20-dione, MO-TMS
|
|
2 | 462.74 |
| 54-056-0 |
2,2,4,6,8-pentamethyl-4,6,8-tri(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 413.73 |
| 54-070-4 |
Thiazolo[5,4-d]pyrimidine, 5-amino-2-[(2-chloroethyl)thio]-7-(ethylamino)-
|
|
2 | 289.82 |
| 54-118-1 |
2,2,4,4,6-pentamethyl-6-(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 261.50 |
| 54-195-6 |
Laminaritriose: bD-Glcp(1->3)-bDGlcp(1->3)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 54-340-4 |
2,6-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 496.90 |
| 54-432-2 |
5«beta»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
|
2 | 539.03 |
| 54-472-8 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
2 | 637.13 |
| 54-567-3 |
3«alpha»,15«alpha»-dihydroxy-5«beta»-androstan-17-one, TMS
|
|
2 | 522.98 |
| 54-619-5 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-4-cholenoic acid, methyl ester, TMS
|
|
2 | 637.13 |
| 54-675-3 |
Benzoic acid, 2-(3-butyl-3-methyl-1-triazeno)-, hydrazide
|
116466-08-1 |
2 | 249.31 |
| 54-724-8 |
5«beta»-Pregnane-3«beta»,17«alpha»-diol-20-one, MO TMS
|
|
2 | 507.90 |
| 54-882-3 |
Trimethylsilyl (2Z)-4-methyl-2-[(trimethylsilyl)oxy]pent-2-enoate
|
|
2 | 274.50 |
| 54-925-5 |
Benzaldehyde, 2-hydroxy, 3-chloro-5-tert.-butyl, oxime, TMS
|
|
2 | 372.05 |
| 54-928-2 |
5«alpha»-Androstane-2«alpha»,3«alpha»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 54-939-0 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMIPS
|
|
2 | 557.01 |
| 55-150-4 |
N6-(cyclotetramethylene-tertbutylsilyl)-2'-Deoxyadenosine, 3',5'-bis-O-TBDMS
|
|
2 | 620.06 |
| 55-182-9 |
3-Acetyl-5-methylmercapto-1,3,4-thiadiazolidone-2-azine
|
109967-13-7 |
2 | 376.50 |
| 55-306-1 |
3-(Pyrrol[3-(1-ethylbutoxy)-1,1,3,3-tetramethyldisiloxanyl]oxymorphomethyl)pyridine
|
|
2 | 341.60 |
| 55-339-5 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M ((dihydro-), TMS
|
|
2 | 321.49 |
| 55-354-8 |
Caffeic acid, O,O'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
180715-88-2 |
2 | 522.94 |
| 55-413-2 |
7«beta»,16«alpha»,17-triOH-kauranoic acid, methyl ester TMS ether
|
|
2 | 583.03 |
| 55-435-8 |
16«beta», 17-H2-17-OH GA20 methyl ester TMS ether
|
|
2 | 508.80 |
| 55-472-7 |
Urea, N-(2-chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitroso-
|
13909-02-9 |
2 | 262.65 |
| 55-613-0 |
7«alpha»,12«alpha»-dihydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
2 | 635.11 |
| 55-638-3 |
3A,17A,21-Trihydroxy-5B-pregnan-20-one, MO TMS
|
|
2 | 596.09 |
| 55-651-8 |
N6-TFA-2'-Deoxyadenosine, 3'-O-TFA, 5'-O-TBDMS
|
|
2 | 557.52 |
| 55-684-2 |
2-(N-tert-Butyldimethylsilyl)amino-4-methylphenol tert-butyldimethylsilyl ether
|
|
2 | 351.67 |
| 55-706-7 |
Benzaldehyde, 2-hydroxy, 3-chloro-5-tert.-octyl, oxime, TMS
|
|
2 | 428.16 |
| 55-759-9 |
2(1H)-Pyrimidinone, 1-[2,3-bis-O-(trimethylsilyl)-«beta»-D-ribofuranosyl]-4-(trimethylsiloxy)-, 5'-[bis(trimethylsilyl) phosphate]
|
32645-59-3 |
2 | 685.09 |
| 55-791-3 |
Silane, dimethyl(dimethyl(but-3-enyloxy)silyloxy)(but-3-enyloxy)-
|
|
2 | 274.50 |
| 55-961-4 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androst-1-en-3-one, 17-TMS
|
|
2 | 374.63 |
| 55-992-0 |
Pregnan-20-one, 3,11,21-tris[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,11«beta»)-
|
56196-42-0 |
2 | 567.04 |
| 56-075-7 |
2,2,4,4,6,6-hexamethyl-8,8,10,10-tetraphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 619.05 |
| 56-110-7 |
5.alpha.-Androst-2-en-3,17.beta.-diol, (3,17-O-)-diTBDMSi
|
|
2 | 518.97 |
| 56-122-4 |
3A,11B,17A,21-Tetrahydroxy-5B-pregnan-20-one, enol, tetrakis-TMS
|
|
2 | 655.23 |
| 56-200-7 |
N-(3-Bromo-4-hydroxy-phenyl)-4-nitro-benzenesulfonamide, N,O-di(tert.-butydiimethylsilyl)-
|
|
2 | 601.71 |
| 56-206-1 |
15(S)-15-Methyl-PGA2, MO-TMS, isomer # 1
|
|
2 | 521.89 |
| 56-340-2 |
«alpha»-D-Mannopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
24707-99-1 |
2 | 541.06 |
| 56-378-1 |
3A,17A,21-Trihydroxy-5A-pregnan-20-one, MO TMS
|
|
2 | 596.08 |
| 56-435-7 |
4-Aminobenzoic acid, N- acetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 407.69 |
| 56-452-8 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M, (HO-alkyl-) isomer-1, AC
|
|
2 | 317.43 |
| 56-461-8 |
4-(7-Ethyl-3-methyl-5-propenyl-2,3-dihydro-benzofuran-2-yl)-2-methoxy-phenol, TMS
|
|
2 | 396.59 |
| 56-481-6 |
Nicotinic acid, 6-[n-[(2-acetamido-3-hydro-4-oxo-6-pteridinyl)methyl]acetamido]
|
30958-64-6 |
2 | 397.34 |
| 56-520-2 |
L-Lysine, N2,N6-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107715-99-1 |
2 | 488.97 |
| 56-565-3 |
5-Pregnen-3-.beta.,15-.beta.,17-.alpha.,20-.alpha.-tetrol, TMS
|
|
2 | 639.23 |
| 56-575-2 |
Indole, 3-(2-acetaminoethyl), 6-hydroxy-5-methoxy (Hydroxymelatonin), TMS
|
|
2 | 392.65 |
| 56-577-0 |
9-Dodecyn-1-ol, dimethyl(dimethyl(dimethyl(dimethyl(pyrid-2-ylmethoxy)silyloxy)silyloxy)silyloxy)silyl ether
|
|
2 | 570.03 |
| 56-616-6 |
3«alpha»,7«beta»,12«alpha»-Trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 639.14 |
| 56-651-7 |
[1,2,5]Oxadiazolo[3,4-d]pyrimidine, 5,7-diamino-, 1-oxide
|
16206-19-2 |
2 | 168.11 |
| 56-676-0 |
3-oxo-4,6-chol-24-oate, O-methyloxime (2)
|
|
2 | 471.75 |
| 56-732-7 |
1H-1,2,3-triazole-4-carboxamide, 5-[3-(p-bromophenyl)-1-triazeno]-
|
7229-15-4 |
2 | 310.11 |
| 56-900-0 |
4-Amino-n-butyl-1,2,5-thiadiazole-3-carboximidamide
|
|
2 | 199.28 |
| 56-912-7 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy cholestan-23-en-26-oic acid, isomer # 1, Me-TMS
|
|
2 | 679.21 |
| 56-920-8 |
Silane, dimethyl(dimethyl(2,3,6-trichlorophenoxy)silyloxy)(2,3,6-trichlorophenoxy)-
|
|
2 | 525.18 |
| 56-936-1 |
Triazolo [4,5-d]pyrimidine-,3h-v-,7(6h)-thione-, 5-amino-3-butyl-
|
92352-41-5 |
2 | 224.29 |
| 56-959-6 |
5-«alpha»-Cholanoic acid, 3-«alpha»-6-«alpha»,7-«alpha»,12-«alpha»-tetrahydroxy, methyl ester, TMS
|
|
2 | 727.32 |
| 57-055-8 |
3,7,11,15-Tetramethyl-2-hexadecenal, O-TBDMS oxime, # 1
|
|
2 | 423.79 |
| 57-064-8 |
2-«beta»,3-«alpha»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 57-235-8 |
Imidazo[1,2-c]pyrimidine-5(1h)-thione, 1-(2-chloroethyl)-2,3-dihydro-
|
7151-75-9 |
2 | 215.70 |
| 57-357-3 |
erythro-Pentonic acid, 3-deoxy-2,4,5-tris-O-(trimethylsilyl)-2-C-[[(trimethylsilyl)oxy]methyl]-, trimethylsilyl ester
|
55517-79-8 |
2 | 541.06 |
| 57-416-7 |
5«alpha»-Androstane-3«beta»,11«beta»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 57-602-0 |
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3,7,9-tetrakis(tert-butyldimethylsilyl)-
|
|
2 | 625.17 |
| 57-612-9 |
5-Pregnane-11-one-3«alpha»,20«alpha»-diol, EO-TMS
|
|
2 | 521.92 |
| 57-615-6 |
17«alpha»-Trenbolone, 3-enol trimethylsilyl ether, 17-trimethylsilyl ether
|
|
2 | 414.74 |
| 57-651-6 |
Azobenzene, 2-chloro-4-nitro-4'-[2-(hydroxyethyl)(ethyl)amino]-
|
|
2 | 348.79 |
| 57-701-0 |
trans-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, metylboronate
|
|
2 | 238.09 |
| 57-796-6 |
5-Ethyl-2-methyl-4-[(trimethylsilyl)oxy]furan-3(2H)-one
|
|
2 | 214.34 |
| 57-872-1 |
O18-2-hydroxy-1,4-benzoxazin-3-one, O-trimethylsilyl
|
|
2 | 237.33 |
| 58-010-6 |
Acetic acid, [3-(4-carbamoylimidazol-5-yl)-2-triazeno]-, ethyl ester
|
3413-78-3 |
2 | 240.22 |
| 58-170-9 |
3«alpha»,6«beta»,7«beta»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 58-173-6 |
L-Ascorbic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-
|
55517-56-1 |
2 | 464.85 |
| 58-186-2 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)octadecyloxy-
|
|
2 | 492.90 |
| 58-215-9 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, nonyl ester
|
|
2 | 443.51 |
|
« Previous Results
Next Results »
|